Nutromics develops a lab-on-a-patch® technology that utilizes multiple DNA-based sensors and microneedles for continuous, real-time biomarker monitoring. This approach addresses the inefficiencies of traditional lab diagnostics, which provide outdated single data points, by enabling timely and dynamic health insights for improved patient outcomes.
Funding
$7.4M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Traditional lab diagnostic processes provide single data points that are several hours old, requiring repeated cycles to produce trend data. This inefficient system can lead to poor patient outcomes and increased healthcare costs, especially for dynamic targets and fast-moving conditions.
Solution
Nutromics is developing a lab-on-a-patch® technology for continuous and real-time diagnostic monitoring. This breakthrough technology combines multiple DNA-based sensors with microneedles to track crucial targets in real-time, providing clinicians with critical, personalized insights. The minimally invasive sensors can detect multiple proteins, drugs, metabolites, and hormones, offering a comprehensive view of a patient's health status.
Target Audience
The primary target audience includes clinicians and healthcare providers who require continuous, real-time monitoring of patient biomarkers for improved treatment and diagnostic accuracy.
Features
- Minimally invasive microneedles for continuous monitoring of multiple targets
- DNA-based sensors that mimic the body's natural sensing mechanisms
- Bluetooth-enabled technology for streaming real-time insights
- Ability to track proteins, drugs, metabolites, and hormones simultaneously
- Continuous data collection eliminates the need for repeated blood draws and lab analysis